Mediolanum International Funds’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.6M Sell
352,546
-88,518
-20% -$7.74M 0.28% 79
2026
Q1
$37.8M Buy
441,064
+77,822
+21% +$6.94M 0.4% 52
2025
Q4
$28.9M Buy
363,242
+57,224
+19% +$4.49M 0.29% 79
2025
Q3
$24.6M Buy
306,018
+91,077
+42% +$7.77M 0.26% 85
2025
Q2
$19.1M Sell
214,941
-132,608
-38% -$12.1M 0.23% 111
2025
Q1
$32.3M Buy
347,549
+147,696
+74% +$13.2M 0.45% 52
2024
Q4
$18.1M Sell
199,853
-201,770
-50% -$19.3M 0.23% 94
2024
Q3
$41.6M Sell
401,623
-14,118
-3% -$1.44M 0.58% 27
2024
Q2
$38.1M Buy
415,741
+17,404
+4% +$1.61M 0.62% 27
2024
Q1
$35.8M Buy
+398,337
New +$33.7M 0.58% 35

Other funds holding CL

Mediolanum International Funds's CL Position: Q2 2026 in Review

Mediolanum International Funds reduced its Colgate-Palmolive (CL) stake by 20% in Q2 2026, selling an estimated $7.74M and leaving 352,546 shares worth $32.6M. The position accounts for 0.28% of the portfolio, ranked #79.

Mediolanum International Funds first reported a position in CL in Q1 2024 and has held it in 10 quarters since. The position peaked at $41.6M in Q3 2024. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Mediolanum International Funds held 352,546 shares of Colgate-Palmolive worth $32.6M as of Q2 2026.
  • Mediolanum International Funds sold 88,518 Colgate-Palmolive shares in Q2 2026, an estimated $7.74M.
  • Colgate-Palmolive made up 0.28% of Mediolanum International Funds's portfolio in Q2 2026, its #79 holding.
  • Mediolanum International Funds first reported a position in Colgate-Palmolive in Q1 2024 and has held it in 10 quarters since.
  • Mediolanum International Funds's Colgate-Palmolive position peaked at $41.6M in Q3 2024.
  • 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Mediolanum International Funds's 13F filing for Q2 2026, filed 23 Jul 2026.